| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015257 | Epilepsy Research | 2015 | 29 Pages |
Abstract
Our findings showed that factors such as younger age, acute neurologic pathology and coma at presentation were associated with IVAD use in patients with NCSE. These factors should be controlled in the future outcome and effectiveness studies to determine the effect of IVAD use on outcome of NCSE.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Utku Uysal, Mark Quigg, Brennen Bittel, Nancy Hammond, Theresa I. Shireman,